Precision BioSciences Inc (DTIL) stock
DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/3058% above fair value
$7.10+0.05 (+0.71%)
Close on Nov 18, 2026Market cap $195.97MP/E –Yield –
Precision BioSciences price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Precision BioSciences's price to book ratio was 5.3× on Nov 11, 2026, against 4.0× a year earlier. Over the last 5 years it ranged from 0.4× to 5.3×, with a median of 1.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 5.3× | +2.3 |
| 2025 | Dec 31, 2025 | 3.0× | +2.6 |
| 2024 | Dec 31, 2024 | 0.4× | −1.0 |
| 2023 | Dec 29, 2023 | 1.5× | −0.1 |
| 2022 | Dec 30, 2022 | 1.6× | −2.8 |
| 2021 | Dec 31, 2021 | 4.4× | −2.5 |
| 2020 | Dec 31, 2020 | 6.9× | +2.3 |
| 2019 | Dec 31, 2019 | 4.5× | – |
See a number that looks wrong?